Johnson & Johnson

NYSE: JNJ
$155.41
+$0.89 (+0.6%)
Real Time Data Delayed 15 Min.

JNJ Articles

With a Federal Reserve rate hike decision, investors have to keep in mind what to think of the stock market heading into the rest of this summer and what to expect for the rest of 2017.
Boeing, 3M, Johnson & Johnson, and Visa all posted new 52-week highs Friday to lead the DJIA's gain for the day.
When companies see their shares rise almost 50%, investors probably just assume the news is from a buyout or a merger. In Tuesday's massive gain in shares of Protagonist Therapeutics, it was that the...
Protagonist Therapeutics saw its shares make a solid gain early on Tuesday after the company announced a key worldwide licensing and collaboration agreement with Janssen Biotech.
The DJIA is trading narrowly lower just minutes before Friday's closing bell. Home Depot and J&J are leading the losers, while Disney and Nike are the leading gainers.
If Warren Buffett is considered the greatest investor of the modern era, and if he has held the title of the world's richest man, then maybe he knows a thing or two.
J&J, Cisco, Caterpillar, and Goldman Sachs led the Dow Industrials higher on Monday.
The top analyst upgrades, downgrades and other research calls from Monday include Applied Materials, Cerner, Cisco Systems, Johnson & Johnson, Level 3 Communications and Salesforce.com.
As the summer approaches, many investors fear that a stock market correction could come at almost any time. Here are the eight most attractive defensive stocks for investors seek refuge in for the...
Goldman Sachs, J&J, American Express, and Travelers were the worst performing DJIA stocks on Tuesday.
Health care giant Johnson & Johnson missed sales estimates but beat analysts' profit target. The $30 billion acquisition of Actelion has been included in revised guidance for the 2017 fiscal year.
24/7 Wall St. has put together a preview of GE, Verizon, IBM and other Dow Jones Industrial Average companies scheduled to report their quarterly results this week.
Adidas has turned to 3D technology to make part of a new line of running shoes. The company eventually will make 100,000 pairs, as it works to find means to stay ahead of rivals such as Nike.
Johnson & Johnson, Intel, Travelers, and DuPont post gains to lead DJIA narrowly higher Thursday.
Johnson & Johnson, Pfizer, UnitedHealth, and Verizon lifted the DJIA on Thursday.